Big Money Sentiment increased to 0.85 in Q3 2018. It has change of 0.07, from 2018Q2’s 0.78. The ratio improved due to PFE positioning: 41 sold and 741 reduced. 142 funds bought positions and 520 increased positions. Investors holded 3.98 billion in 2018Q2 but now own 3.96 billion shares or 0.44% less. Wharton Business Grp Inc Limited Liability reported 10,399 shs. Spectrum Asset Mngmt Inc (Nb Ca) has 1.32% invested in Pfizer Inc. (NYSE:PFE). Us Savings Bank De invested in 8.02 million shs or 1.02% of the stock. Drexel Morgan And has 5,488 shs for 0.21% of their capital. King Luther Capital Mgmt reported 2.98M shs. Independent Investors stated it has 0.44% in Pfizer Inc. (NYSE:PFE). Mycio Wealth Ptnrs Ltd reported 46,699 shs stake. Nichols & Pratt Advisers Limited Liability Partnership Ma owns 0.31% invested in Pfizer Inc. (NYSE:PFE) for 85,684 shs. Los Angeles Mgmt And Equity Rech Inc stated it has 1.26M shs or 0.29% of all its holdings. Metropolitan Life Insur Communication Ny, a New York-based fund reported 845,941 shs. Lombard Odier Asset Mgmt (Europe) Ltd holds 0.18% of its capital in Pfizer Inc. (NYSE:PFE) for 59,368 shs. Capital Guardian Trust, a California-based fund reported 100,293 shs. Financial Bank Of Montreal Can invested 0.76% of its capital in Pfizer Inc. (NYSE:PFE). Iowa Bancorp accumulated 126,573 shs. Clinton Grp Inc owns 20,626 shs for 0.33% of their capital.

PFE registered $1.92 million net activity with 0 buys and 2 sales since July 20, 2018. $1.50 million worth of Pfizer Inc. (NYSE:PFE) shs were sold by SUSMAN SALLY.

In 2018Q3 Securities and Exchange form is reported Usca Ria Llc’s stake in Pfizer Inc (PFE) which was reduced by 39.43%. By selling 180,329 shares Usca Ria Llc made the stock popped up with 5.56%. At the end of 2018Q3, the institutional investor held 277,008 shares of the health care company, valued at $12.21 million, down from 457,337 at the end of the previous reported quarter. Usca Ria Llc has risen its stake in Wells Fargo Co New (NYSE:WFC) and also increased its holding in Metlife Inc (NYSE:MET) by 92,527 shares in the quarter, for a total of 130,039 shares.

Pfizer Inc. (NYSE:PFE)’s earnings release is expected by WallStreet on January, 29, as reported by Faxor. Last year’s earnings per share was $0.62, while now analysts expect change of 3.23 % up from current $0.64 earnings per share. In case of $0.64 earnings per share PFE’s profit could be $3.70 billion. -17.95 % negative EPS growth is what analysts predict. $0.78 earnings per share was revealed for previous quarter.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

A total of 7 analysts rate Pfizer (NYSE:PFE) as follows: 2 “Buy”, 4 “Hold” and 1 “Sell”. Тherefore 29% are bullish. The firm has $46 highest and $37 lowest target. The avg target $42.43 is -2.30% below the last ($43.43) price. (NYSE:PFE) has 9 ratings reports on Jan 9, 2019 according to StockzIntelligence. On Wednesday, October 31 the stock has “Neutral” rating by Credit Suisse. On Thursday, November 1 the rating was downgraded by BMO Capital Markets to “Market Perform”. In Wednesday, August 1 report BMO Capital Markets maintained it with “Outperform” rating and $44 target. On Tuesday, November 6 the rating was maintained by Citigroup with “Sell”. The company rating was maintained by Morgan Stanley on Thursday, August 23. On Thursday, August 23 the stock has “Equal-Weight” rating by Barclays Capital. In Wednesday, August 1 report Bank of America maintained the stock with “Buy” rating. On Tuesday, December 11 the company was downgraded by JP Morgan. On Wednesday, August 1 the company was maintained by Credit Suisse.